Quarterly report (Form 10-Q)
West Pharmaceutical Services 10-Q for Quarter ended Jun 30, 2026
Filing excerpt
These increases were partially offset by our revenue growth being negatively impacted by approximately $7 million from production downtime associated with the Company’s May 2026 cyber incident.